What could be the cause of anemia and recurrent moderate-grade fever in a patient with a hemoglobin level of 9.2 g/dL, no signs of bleeding, and improved overall well-being?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Hemolytic Anemia Secondary to Megaloblastic Anemia

The most likely cause of this patient's rapid hemoglobin drop from 12 to 9.2 g/dL over 24 hours with persistent fever is acute hemolytic anemia secondary to severe megaloblastic anemia (vitamin B12 or folate deficiency), which can present with high-grade fever mimicking tropical infection. 1, 2

Key Diagnostic Features Supporting This Diagnosis

Hemolytic Pattern Without Bleeding

  • A 2.8 g/dL hemoglobin drop in 24 hours without visible bleeding strongly suggests hemolysis rather than blood loss 2
  • Megaloblastic anemia causes ineffective erythropoiesis and intramedullary hemolysis, leading to rapid hemoglobin decline 1, 3
  • The combination of fever, anemia, and absence of bleeding is characteristic of megaloblastic anemia presenting as a febrile illness 1

Fever Pattern in Megaloblastic Anemia

  • Fever occurs in approximately 40% of patients with megaloblastic anemia and can reach temperatures >103°F (39.4°C) 3
  • High-grade fever (>101°F) with megaloblastic anemia has a mean duration of 7.7 days (range 4-18 days) 1
  • The moderate-grade fever occurring twice daily fits this pattern 1
  • Fever in megaloblastic anemia typically resolves within 1-5 days (mean 2.6 days) after initiating vitamin B12 or folic acid therapy 1, 3

Clinical Improvement Despite Anemia

  • The paradoxical improvement in overall well-being and good appetite despite worsening anemia is consistent with megaloblastic anemia, where systemic symptoms may improve even before hematologic parameters normalize 1
  • This contrasts with infectious causes where clinical deterioration typically accompanies worsening anemia 4

Essential Immediate Laboratory Workup

First-Line Tests to Confirm Diagnosis

  • Complete blood count with mean corpuscular volume (MCV) - expect MCV ≥110 fL, especially if temperature ≥103°F 1
  • Peripheral blood smear - look for hypersegmented neutrophils and macro-ovalocytes 1, 2
  • Reticulocyte count - typically low or inappropriately normal for degree of anemia 2
  • Lactate dehydrogenase (LDH) - expect marked elevation (mean 814 ± 24 IU/L in megaloblastic anemia with fever) 1
  • Unconjugated bilirubin - elevated in 75% of cases due to intramedullary hemolysis 1
  • Serum vitamin B12 and folate levels - 87.5% of patients with megaloblastic anemia and fever have documented deficiency 1

Critical Tests to Exclude Alternative Diagnoses

  • Thick and thin blood smears for malaria - mandatory given fever and anemia, as malaria can present identically 4, 5
  • Direct Coombs test - to exclude autoimmune hemolytic anemia 2
  • Haptoglobin and indirect bilirubin - to confirm hemolysis 2
  • White blood cell count - leucopenia ≤3000/cumm is significantly associated with temperature ≥103°F in megaloblastic anemia 1

Immediate Management Algorithm

Step 1: Initiate Empiric Vitamin Therapy While Awaiting Results

  • Start parenteral vitamin B12 (1000 mcg IM daily) immediately if megaloblastic anemia is suspected 1, 2
  • Add folic acid 1-5 mg daily orally 1
  • Monitor temperature closely - defervescence within 1-5 days confirms diagnosis 1, 3
  • Failure of fever to resolve rapidly suggests alternative diagnosis requiring further investigation 3

Step 2: Transfusion Decision

  • Do NOT transfuse at hemoglobin 9.2 g/dL in a stable patient without active bleeding, cardiovascular symptoms, or severe hypoxemia 4, 6
  • The restrictive transfusion threshold of <7.0 g/dL is recommended in most hospitalized patients 4, 6
  • Monitor hemoglobin daily until stable 4

Step 3: Monitor for Treatment Response

  • Expect reticulocytosis within 3-5 days of vitamin therapy initiation 1
  • Hemoglobin should begin rising within 1 week 1
  • Temperature normalization within 1-5 days confirms megaloblastic anemia as cause 1, 3

Alternative Diagnoses to Consider

Malaria

  • Must be excluded in any patient with fever and anemia, especially with travel history 4
  • Plasmodium falciparum can cause rapid hemoglobin decline and fever 4
  • Blood smears should be checked every 12 hours if initial smears are negative but suspicion remains high 4

Drug-Induced Hemolytic Anemia

  • Ceftriaxone and other cephalosporins can cause immune-mediated hemolytic anemia 7
  • Review all medications, including recent antibiotic use 7
  • Severe cases including fatalities have been reported 7

Hemolytic Uremic Syndrome or TTP

  • Less likely given improved clinical status and good appetite 2
  • Would expect more severe systemic symptoms and potential renal dysfunction 2

Common Pitfalls to Avoid

Diagnostic Pitfalls

  • Do not dismiss megaloblastic anemia as a cause of high-grade fever - it is frequently overlooked because fever is not widely recognized as a presenting feature 1, 2
  • Do not delay vitamin therapy while awaiting confirmatory test results - empiric treatment is safe and diagnostic response confirms the diagnosis 1, 3
  • Do not attribute fever solely to infection without checking vitamin levels - this leads to unnecessary antibiotics and delayed diagnosis 1, 2

Management Pitfalls

  • Do not transfuse based solely on hemoglobin level - assess hemodynamic stability, symptoms, and oxygen delivery 4, 6
  • Do not stop vitamin therapy if fever persists beyond 5 days - this suggests concurrent infection or alternative diagnosis requiring additional workup 3
  • Do not overlook malaria in the differential - it can present identically and requires immediate treatment 4

Monitoring Pitfalls

  • Do not assume clinical improvement means hemoglobin is stable - continue daily monitoring until hemoglobin stabilizes 4, 6
  • Do not miss concurrent vitamin D deficiency - it can coexist with B12 deficiency and contribute to symptoms 2

References

Research

Fever in megaloblastic anemia.

Southern medical journal, 1979

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Severe Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.